C Heirman Selected Research

Antigens

10/2013	A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients.
4/2006	Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors.
11/2000	A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

C Heirman Research Topics

Disease

6	Neoplasms (Cancer) 03/2015 - 11/2000
3	Melanoma (Melanoma, Malignant) 11/2013 - 11/2000
1	Communicable Diseases (Infectious Diseases) 03/2014
1	Neoplasm Metastasis (Metastasis) 11/2000

Drug/Important Bio-Agent (IBA)

3	AntigensIBA 10/2013 - 11/2000
2	CytokinesIBA 04/2014 - 03/2014
1	Interferon-alpha (Interferon Alfa)IBA 03/2015
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2013
1	Small Interfering RNA (siRNA)IBA 11/2013
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 11/2013
1	Transcription Factors (Transcription Factor)IBA 11/2013
1	Toll-Like Receptor 4IBA 10/2013
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2013
1	Proteins (Proteins, Gene)FDA Link 10/2013
1	Messenger RNA (mRNA)IBA 10/2013
1	Monophenol Monooxygenase (Tyrosinase)IBA 10/2013
1	CD40 Ligand (CD40L)IBA 10/2013
1	Peptides (Polypeptides)IBA 11/2000
1	EpitopesIBA 11/2000
1	HLA-DPw4 antigenIBA 11/2000

Therapy/Procedure

2	Immunotherapy 10/2013 - 11/2000